Drug delivery systems using polymer nanoassemblies for cancer treatment

Therapeutic Delivery

Volumn 1, Issue 3, 2010, Pages 361-363

  Bae, Younsoo ^a  

^a University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; NANOPARTICLE; POLYMER;

CANCER COMBINATION CHEMOTHERAPY; CANCER THERAPY; CONTROLLED DRUG RELEASE; DRUG BINDING SITE; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG PENETRATION; DRUG RETENTION; DRUG SOLUBILITY; DRUG TARGETING; DRUG TUMOR LEVEL; EXCIPIENT COMPATIBILITY; HUMAN; HYDROPHOBICITY; MICELLE; NANOPHARMACEUTICS; NEOPLASM; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; WALKER WARBURG SYNDROME;

EID: 79954486971     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.10.28     Document Type: Review

References (18)

1. Nishiyama N, Bae Y, Miyata K, Fukushima S, Kataoka K. Smart polymeric micelles for gene and drug delivery. Drug Discov. Today, Technol. 2, 1-26 (2005).
2. Putnam D, Kopecek J. Polymer conjugates with anticancer activity. Adv. Polym. Sci. 122, 55-123 (1995).
3. Webber SE, Munk P, Tuzar Z. Solvents and self-organization of polymers. Kluwer Academic Publishers 327, 383-407 (1996).
4. Bae Y, Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv. Drug Delivery Rev. 61, 768-784 (2009).
5. Anraku Y, Kishimura A, Oba M, Yamasaki Y, Kataoka K. Spontaneous formation of nanosized unilamellar polyion complex vesicles with tunable size and properties. J. Am. Chem. Soc. 132, 1631-1636 (2010).
6. Kim JO, Kabanov AV, Tatiana BK. Polymer micelles with crosslinked polyanion core for delivery of a cationic drug doxorubicin. J. Control. Release 138, 197-204 (2009).
7. Jain RK, Munn LL, Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer 2, 266-276 (2002). (Pubitemid 37328780)
8. Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug 6, 193-210 (1989). (Pubitemid 20065994)
9. Kano MR, Bae Y, Iwata C, Morishita Y, et al. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-b signaling. Proc. Natl Acad. Sci. USA 104, 3460-3465 (2007). (Pubitemid 46364181)
10. Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Delivery Rev. 60, 1615-1626 (2008).
11. Bae Y, Nishiyama N, Kataoka K. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjugate Chem. 18, 1131-1139 (2007). (Pubitemid 47122634)
12. Hamad I, Moghimi SM. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug. Expert Opin. Drug Del. 5, 205-219 (2008). (Pubitemid 351308312)
13. Hoffman AS. The origins and evolution of 'controlled' drug delivery systems. J. Control. Release 132, 153-163 (2008).
14. West KR, Otto S. Reversible covalent chemistry in drug delivery. Curr. Drug Discov. Technol. 2, 123-160 (2005). (Pubitemid 41242960)
15. Kratz F, Beyer U, Schutte MT. Drug-polymer conjugates containing acid-cleavable bonds. Crit. Rev. Ther. Drug 16, 245-288 (1999). (Pubitemid 29305204)
16. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
17. Smalley KSM, Haass NK, Brafford PA, Lioni M, Flaherty KT, Herlyn M. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol. Cancer Ther. 5, 1136-1144 (2006). (Pubitemid 43881305)
18. Vicent MJ, Greco F, Nicholson RI, Paul A, Griffiths PC, Duncan R. Polymer therapeutics designed for a combination therapy of hormone-dependent cancer. Angew. Chem. Int. Ed. 44, 4061-4066 (2005). (Pubitemid 40886448)